関連ニュース

InnovAge's filling existing centers and controlling care costs could turn their continued enrollment growth into faster earnings growth in the long run. So, if their operating recovery materializes, i

InnovAge Holding Corp. remains a Buy as profitability and cash flow have improved, despite shares rising over 30%. INNV's fiscal 2026 revenue grew 15.9% to $989.7M, with adjusted EBITDA margin expandi

InnovAge Holding Corp. (INNV) Q4 2026 Earnings Call Transcript